Institution
Zentrum für Innovation und Technik in Nordrhein-Westfalen
DEcompany
Recent research
- Health & Medicine
Abstract Developing highly selective PARP1 inhibitors is a promising strategy to improve the therapeutic window compared with dual PARP1/2 inhibitors. Through structure-guided design and optimization, we developed (R)-A17, a novel, highly selective PARP1 inhibitor featuring a uni...